Powered by our DarwinSeq platform, our main goal is to help accelerate drug development. By learning how proteins naturally interact with each other, our DarwinSeq platform accelerates the pace of peptide discovery by providing libraries of peptides with therapeutic potential.

Using our novel technology platform to design highly specific binding peptides, we are developing intellectual property and advancing research and development in the areas of new synthetic drugs, immunotherapies and other unique applications.

NuvoBio

Org chart

Teams

Offices